Skip to content

Bio-Rad Laboratories, Inc. BIO.B Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$5.6M-444%
RBC Bearings logo
RBC BearingsRBC
$400K
Flutter Entertainment logo
Flutter EntertainmentFLUT
$0
Ameren logo
AmerenAEE
$355M+24.6%
Devon Energy logo
Devon EnergyDVN
$1M0.0%
Veeva Systems logo
Veeva SystemsVEEV
$242.45M+25.2%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
Bio-Rad Laboratories, Inc. (BIO.B) reported other comprehensive income unrealized holding gain loss on securities arising during period net of tax of -$6M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax changed year-over-year?
Bio-Rad Laboratories, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax decreased by 220.0% year-over-year, from $5M to -$6M.